The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review

Alcoholism, Clinical and Experimental Research
Erica Grodin, Lara A Ray

Abstract

Alcohol use disorder (AUD) is a chronic relapsing condition that represents a significant public health concern. Pharmacological treatment development for AUD is a top research priority, and many studies are being conducted to evaluate potential AUD treatments. Understanding the brain circuitry impacted by addiction is crucial for the development of efficacious pharmacological interventions. These neuroadaptations can be probed noninvasively using functional magnetic resonance neuroimaging (fMRI). fMRI may be an effective tool to identify biomarkers for AUD pharmacotherapies, evaluating changes associated with pharmacological treatment. Thus, the present qualitative review of the literature focuses on the role of fMRI as a tool for medication development for AUD. The aim of this review was to assemble research across a range of fMRI paradigms to study the effectiveness of pharmacological treatments of adult AUD. First, we present a qualitative review of fMRI AUD pharmacotherapy studies, differentiating studies based on their dosing regimen. Second, we provide recommendations for the field to improve the use of fMRI as a biomarker for AUD pharmacotherapy.

References

Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P T Fox, M E Raichle
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·R D HogeG B Pike
Feb 12, 2002·Nature Reviews. Neuroscience·David J Heeger, David Ress
Oct 27, 2004·NeuroImage·Richard B BuxtonThomas T Liu
Aug 11, 2006·Alcoholism, Clinical and Experimental Research·Derik HermannAndreas Heinz
May 10, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Elise M WeertsMary E McCaul
May 15, 2007·Magnetic Resonance Imaging·G D Iannetti, Richard G Wise
Feb 16, 2008·Science·David T GeorgeMarkus Heilig
Mar 4, 2008·Biological Psychiatry·Melissa M NorbergDavid F Tolin
Mar 5, 2009·Pharmacology, Biochemistry, and Behavior·Charlotte A BoettigerHoward L Fields
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Lara A RayKaren Miotto
Mar 6, 2010·Annals of the New York Academy of Sciences·Christian A Heidbreder, Amy H Newman
Jun 24, 2010·Journal of Clinical Psychopharmacology·Hugh MyrickRaymond F Anton
Jul 23, 2011·Alcoholism, Clinical and Experimental Research·Mira Bühler, Karl Mann
Dec 27, 2011·Neuroscience and Biobehavioral Reviews·Yavor YalachkovMarcus J Naumer
Aug 4, 2012·Biological Psychiatry·Lianne SchmaalAnna E Goudriaan
Aug 29, 2012·Journal of Clinical Psychopharmacology·Jens M LangoschHans M Olbrich
Oct 4, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joseph P SchachtHugh Myrick
Jul 25, 2013·CNS Drugs·Mark J Niciu, Albert J Arias
Nov 21, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura E KwakoMarkus Heilig
Nov 26, 2014·Alcoholism, Clinical and Experimental Research·Karl MannMichael N Smolka
Jan 13, 2015·Alcoholism, Clinical and Experimental Research·Primavera A SpagnoloMarkus Heilig
Jul 26, 2015·The International Journal of Neuropsychopharmacology·Vatsalya VatsalyaVijay A Ramchandani
Oct 6, 2015·Addiction Biology·Kelly E CourtneyLara A Ray
Jan 27, 2016·Expert Opinion on Pharmacotherapy·Michael Soyka
Mar 20, 2016·Alcoholism, Clinical and Experimental Research·James MacKillop
Apr 12, 2016·Alcoholism, Clinical and Experimental Research·Joshua L GowinVijay A Ramchandani
Apr 26, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Melanie L SchwandtMarkus Heilig
May 18, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Elizabeth A CabreraGene-Jack Wang
Aug 1, 2016·The Lancet. Psychiatry·George F Koob, Nora D Volkow
Nov 2, 2016·Behavioural Pharmacology·Mary R Lee, Elise M Weerts
Jan 20, 2017·Alcoholism, Clinical and Experimental Research·Ismene L Petrakis, Tracy L Simpson

❮ Previous
Next ❯

Citations

May 15, 2020·Alcoholism, Clinical and Experimental Research·Aaron C LimLara A Ray
Jan 21, 2021·Annual Review of Clinical Psychology·Lara A Ray, Erica N Grodin
Aug 20, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ahmet O CeceliRita Z Goldstein
Sep 30, 2021·Alcoholism, Clinical and Experimental Research·Elizabeth M BurnetteErica N Grodin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

© 2021 Meta ULC. All rights reserved